Trademark: 97770124
Word
BASECURE THERAPEUTICS
Status Date
Monday, March 4, 2024
Filing Date
Friday, January 27, 2023
Abandoned Date
Monday, February 5, 2024
5 Medicines for human purposes; chemico-pharmaceutical preparations; drugs for medical purposes; pharmaceutical preparations for suppressing tumors; Anti-cancer preparations; pharmaceutical preparations for the prevention and treatment of cancer; sarkomycin preparations; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; Pharmaceuticals for the treatment of cancer; cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of hypertension; pharmaceutical preparations for treating cardiovascular diseases; cardiovascular agents for medical purposes; vasopressin; Vasoconstrictors; pharmaceutical preparations for the treatment of diabetes; Anti-diabetic pharmaceuticals; pharmaceutical preparations and substances for the treatment of metabolic diseases and disorders; pharmaceutical preparations for treating hypoglycemia; lipotropic factor preparations; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for the central nervous system; pharmaceutical preparations for the peripheral nervous system; autonomic drugs for medical purposes; nervines; Pharmaceutical products for treating respiratory diseases; Pharmaceutical preparations to be inhaled for the prevention and treatment of respiratory diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; antivirals; Pharmaceutical preparations for the treatment of chronic liver diseases
42 Scientific laboratory services; scientific research; scientific research for medical purposes in the field of cancerous diseases; scientific surveys for medical purpose; research and development of new products for others; pharmaceutical research and development; drug development; Conducting early evaluations in the field of new pharmaceuticals; development of pharmaceutical preparations and medicines; medical research; clinical trials; structural and functional analysis of genomes; biomedical research; Research and development services in the field of antibodies; Medical research in the field of epidemiology; research and development services relating to vaccines
The mark consists of a stylized DNA structure to the left of the words BASECURE THERAPEUTICS. The mark is all dark blue except for a stylized curve in the bottom of the DNA structure and the U in BASECURE.
BASE CURE THERAPEUTICS
The color(s) yellow and dark blue is/are claimed as a feature of the mark.
Mar 4, 2024
Abandonment Notice E-Mailed - Failure To Respond
Mar 4, 2024
Abandonment - Failure To Respond Or Late Response
Nov 2, 2023
Notification Of Non-Final Action E-Mailed
Nov 2, 2023
Non-Final Action E-Mailed
Nov 2, 2023
Non-Final Action Written
Oct 26, 2023
Assigned To Examiner
Feb 16, 2023
Notice Of Design Search Code E-Mailed
Feb 15, 2023
New Application Office Supplied Data Entered
Jan 31, 2023
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
